Among the drugs Samsung will manufacture for UCB is an anti-Tau candidate to treat progressive supranuclear palsy ... both for myasthenia gravis. The new deal, which is the third between the ...

"The newer medications that are coming out, and a lot of them are approved, are much more focused on the problem," explains ...